Icon reflects on Firecrest deal, sees Pfizer as likely beneficiary
The acquisition of site optimisation specialist Firecrest is good news for customers including US drug giant Pfizer says Alan Morgan, group president of clinical services at Icon.
The acquisition of site optimisation specialist Firecrest is good news for customers including US drug giant Pfizer says Alan Morgan, group president of clinical services at Icon.
Valertias has received the European CE Mark for V-GO its disposable insulin delivery device, further expanding its approval portfolio.
Blue Chip Patient Recruitment says the future of patient sourcing for clinical trials lies in social media.
Chiltern have established a legal entity in Israel after receiving an influx of requests for Israeli patients from clients.
Express Script will take over fellow PBM Medco after a definitive merger agreement was unanimously approved by the boards of directors of both companies.